ECSP982599A - THERMODYNAMICALLY STABLE MODIFICATION OF 1- (4-CARBAZOLILOXI) -3- [2- (2-METOXIFENOXI) ETILAMINO] -2-PROPANOL, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT - Google Patents
THERMODYNAMICALLY STABLE MODIFICATION OF 1- (4-CARBAZOLILOXI) -3- [2- (2-METOXIFENOXI) ETILAMINO] -2-PROPANOL, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS ITInfo
- Publication number
- ECSP982599A ECSP982599A ECSP982599A ECSP982599A EC SP982599 A ECSP982599 A EC SP982599A EC SP982599 A ECSP982599 A EC SP982599A EC SP982599 A ECSP982599 A EC SP982599A
- Authority
- EC
- Ecuador
- Prior art keywords
- propanol
- pharmaceutical composition
- metoxifenoxi
- carbazoliloxi
- etilamino
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000004048 modification Effects 0.000 title abstract 2
- 238000012986 modification Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 title 1
- CIJJLAPROGIMIE-UHFFFAOYSA-N 1-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol Chemical compound COC1=CC=CC=C1OCCNCC(C)O CIJJLAPROGIMIE-UHFFFAOYSA-N 0.000 abstract 1
- NPAKNKYSJIDKMW-UHFFFAOYSA-N carvedilol Chemical compound COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=NC3=CC=C[CH]C3=C12 NPAKNKYSJIDKMW-UHFFFAOYSA-N 0.000 abstract 1
- 229960004195 carvedilol Drugs 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
La presente invenciíon se relaciona con una nueva modificación termodinámicamente estable de 1-4-carbazoliloxi)-3[2-(2metoxifenoxi) etilamino]-2-propanol (Carvedilol), sal farmacológicamente estable, o formas ópticamente activas de ella, procesos para la preparación y composición farmacéuticas que la contienen.The present invention relates to a new thermodynamically stable modification of 1-4-carbazolyloxy) -3 [2- (2methoxyphenoxy) ethylamino] -2-propanol (Carvedilol), pharmacologically stable salt, or optically active forms thereof, processes for the pharmaceutical composition and preparation containing it.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982599 ECSP982599A (en) | 1998-07-21 | 1998-07-21 | THERMODYNAMICALLY STABLE MODIFICATION OF 1- (4-CARBAZOLILOXI) -3- [2- (2-METOXIFENOXI) ETILAMINO] -2-PROPANOL, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982599 ECSP982599A (en) | 1998-07-21 | 1998-07-21 | THERMODYNAMICALLY STABLE MODIFICATION OF 1- (4-CARBAZOLILOXI) -3- [2- (2-METOXIFENOXI) ETILAMINO] -2-PROPANOL, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982599A true ECSP982599A (en) | 1999-06-11 |
Family
ID=42043519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982599 ECSP982599A (en) | 1998-07-21 | 1998-07-21 | THERMODYNAMICALLY STABLE MODIFICATION OF 1- (4-CARBAZOLILOXI) -3- [2- (2-METOXIFENOXI) ETILAMINO] -2-PROPANOL, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982599A (en) |
-
1998
- 1998-07-21 EC ECSP982599 patent/ECSP982599A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9810776A (en) | Thermodynamically stable modification of 1- (4-carbazolyloxy) -3- [2- (2-methoxyphenoxy) ethylamino] -2-propanol, process for its preparation and pharmaceutical compositions containing the same | |
| BR9810802B1 (en) | compound, pharmaceutical composition, and process for the preparation of a compound. | |
| SE0100901D0 (en) | New composition | |
| CY1107294T1 (en) | LOCAL COMPOSITION CONTAINING A VITAMIN D OR A VERSION OF VITAMIN D AND A VULNERABLE CYTICOSTEROID | |
| TR199901077A2 (en) | �spen�iyari form�lasyonlar. | |
| AR032293A1 (en) | PHARMACEUTICAL CASE | |
| DE69719755D1 (en) | POLYMORPHIC CONNECTIONS | |
| PT1414816E (en) | FLIBANSERIN STABILIZABLE POLYMORPHINE, TECHNICAL PROCESS FOR PREPARING AND USING THE PREPARATION OF MEDICINES | |
| DK1017684T3 (en) | Contrast agent for imaging infarcts and necrosis | |
| PT1154986E (en) | PROCESS FOR THE PREPARATION OF IOPAMIDOL | |
| UY27461A1 (en) | PSEUDOPOLIMORFICAS FORMS OF CARDEVILOL. | |
| ECSP045348A (en) | "PROCEDURES FOR THE PREPARATION OF COMBRETASTATINAS" | |
| NO20016151L (en) | Preparation of substituted piperidin-4-ones | |
| PA8451301A1 (en) | A NEW SALT | |
| ES2186989T3 (en) | MALTITOL CRYSTALS OF SPECIFIC FORMS, CRYSTAL COMPOUNDS THAT CONTAIN THEM AND PROCEDURES FOR THEIR PREPARATION. | |
| ECSP982599A (en) | THERMODYNAMICALLY STABLE MODIFICATION OF 1- (4-CARBAZOLILOXI) -3- [2- (2-METOXIFENOXI) ETILAMINO] -2-PROPANOL, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT | |
| EA200100802A1 (en) | APPLICATION OF TIANEPTIN IN THE PREPARATION OF MEDICINES INTENDED FOR THE TREATMENT OF NEURODEGENERATIVE PATHOLOGIES | |
| BR9908199A (en) | Sulfonamide derivatives | |
| BR0208593A (en) | Method for the treatment of a mammal, compound, and, pharmaceutical composition | |
| ATE227997T1 (en) | PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION OF THIOCOLCHICOSIDE | |
| BR9909627A (en) | Process for the production of r - (+) - 6-carboxyamido-3-n-methyl-mino-1,2,3,4-tetrahydrocarbazole | |
| AR021343A1 (en) | NEW ACETALS DERIVED FROM THE 2-RENT-5-HALO-3- [2 '- (TETRAZOL-5-IL) -BIFENIL-4-ILMETIL] -3H-IMIDAZOL-4-CARBALDEHIDS | |
| ES2172214T3 (en) | PROCEDURE FOR IDENTIFICATION OF AN IMAGE OR DOCUMENT. | |
| BR9905904A (en) | Spiro imidazoline compounds, a process for their preparation and pharmaceutical compositions containing the same | |
| UY27824A1 (en) | NEW FORMULATION FOR THE PARENTERAL ADMINISTRATION OF CROBENETINE. |